| Dr Nitin Arora, MD | |
|
107 Prospect St, Attica, NY 14011-1149 | |
| (585) 591-6000 | |
| Not Available |
| Full Name | Dr Nitin Arora |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 21 Years |
| Location | 107 Prospect St, Attica, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659682441 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 268535 (New York) | Secondary |
| 208M00000X | Hospitalist | 268535 (New York) | Secondary |
| 207R00000X | Internal Medicine | 268535 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| United Memorial Medical Center | Batavia, NY | Hospital |
| Rochester General Hospital | Rochester, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| United Memorial Medical Center | 0547259376 | 180 |
News Archive
Results of the highly anticipated Best Oral Presentation and Best Poster Awards were announced at SingHealth Duke-NUS Scientific Congress 2012, held on 3 and 4 August 2012 at the Raffles City Convention Centre.
The first global analysis of existing scientific studies related to COVID-19 and newborn babies highlights that it is uncommon for babies aged up to four weeks old to become infected with the virus, with recorded cases experiencing only mild symptoms and making a full recovery.
MorphoSys AG announced that it has received a milestone payment from Novartis in connection with the initiation of a clinical phase 1 trial with a novel HuCAL antibody. The antibody will be tested in the field of prevention of thrombosis. This is the twelfth therapeutic antibody based on MorphoSys's technologies that Novartis is evaluating in clinical trials. Financial details were not disclosed.
Even after she left her alcoholic, abusive husband behind, Patrice, a nurse in Florida, couldn't summon the energy to keep her house straight, couldn't sleep.
› Verified 2 days ago
| Entity Name | Niagara Falls Memorial Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285717298 PECOS PAC ID: 0244134484 Enrollment ID: O20040413001290 |
News Archive
Results of the highly anticipated Best Oral Presentation and Best Poster Awards were announced at SingHealth Duke-NUS Scientific Congress 2012, held on 3 and 4 August 2012 at the Raffles City Convention Centre.
The first global analysis of existing scientific studies related to COVID-19 and newborn babies highlights that it is uncommon for babies aged up to four weeks old to become infected with the virus, with recorded cases experiencing only mild symptoms and making a full recovery.
MorphoSys AG announced that it has received a milestone payment from Novartis in connection with the initiation of a clinical phase 1 trial with a novel HuCAL antibody. The antibody will be tested in the field of prevention of thrombosis. This is the twelfth therapeutic antibody based on MorphoSys's technologies that Novartis is evaluating in clinical trials. Financial details were not disclosed.
Even after she left her alcoholic, abusive husband behind, Patrice, a nurse in Florida, couldn't summon the energy to keep her house straight, couldn't sleep.
› Verified 2 days ago
| Entity Name | United Memorial Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902800352 PECOS PAC ID: 0547259376 Enrollment ID: O20040507000847 |
News Archive
Results of the highly anticipated Best Oral Presentation and Best Poster Awards were announced at SingHealth Duke-NUS Scientific Congress 2012, held on 3 and 4 August 2012 at the Raffles City Convention Centre.
The first global analysis of existing scientific studies related to COVID-19 and newborn babies highlights that it is uncommon for babies aged up to four weeks old to become infected with the virus, with recorded cases experiencing only mild symptoms and making a full recovery.
MorphoSys AG announced that it has received a milestone payment from Novartis in connection with the initiation of a clinical phase 1 trial with a novel HuCAL antibody. The antibody will be tested in the field of prevention of thrombosis. This is the twelfth therapeutic antibody based on MorphoSys's technologies that Novartis is evaluating in clinical trials. Financial details were not disclosed.
Even after she left her alcoholic, abusive husband behind, Patrice, a nurse in Florida, couldn't summon the energy to keep her house straight, couldn't sleep.
› Verified 2 days ago
| Entity Name | Niagara Falls Memorial Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982659256 PECOS PAC ID: 0244134484 Enrollment ID: O20040524000510 |
News Archive
Results of the highly anticipated Best Oral Presentation and Best Poster Awards were announced at SingHealth Duke-NUS Scientific Congress 2012, held on 3 and 4 August 2012 at the Raffles City Convention Centre.
The first global analysis of existing scientific studies related to COVID-19 and newborn babies highlights that it is uncommon for babies aged up to four weeks old to become infected with the virus, with recorded cases experiencing only mild symptoms and making a full recovery.
MorphoSys AG announced that it has received a milestone payment from Novartis in connection with the initiation of a clinical phase 1 trial with a novel HuCAL antibody. The antibody will be tested in the field of prevention of thrombosis. This is the twelfth therapeutic antibody based on MorphoSys's technologies that Novartis is evaluating in clinical trials. Financial details were not disclosed.
Even after she left her alcoholic, abusive husband behind, Patrice, a nurse in Florida, couldn't summon the energy to keep her house straight, couldn't sleep.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nitin Arora, MD 107 Prospect St, Attica, NY 14011-1149 Ph: (585) 591-6000 | Dr Nitin Arora, MD 107 Prospect St, Attica, NY 14011-1149 Ph: (585) 591-6000 |
News Archive
Results of the highly anticipated Best Oral Presentation and Best Poster Awards were announced at SingHealth Duke-NUS Scientific Congress 2012, held on 3 and 4 August 2012 at the Raffles City Convention Centre.
The first global analysis of existing scientific studies related to COVID-19 and newborn babies highlights that it is uncommon for babies aged up to four weeks old to become infected with the virus, with recorded cases experiencing only mild symptoms and making a full recovery.
MorphoSys AG announced that it has received a milestone payment from Novartis in connection with the initiation of a clinical phase 1 trial with a novel HuCAL antibody. The antibody will be tested in the field of prevention of thrombosis. This is the twelfth therapeutic antibody based on MorphoSys's technologies that Novartis is evaluating in clinical trials. Financial details were not disclosed.
Even after she left her alcoholic, abusive husband behind, Patrice, a nurse in Florida, couldn't summon the energy to keep her house straight, couldn't sleep.
› Verified 2 days ago